Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michail Doukas

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Plos One|January 25, 2023
Targeted next-generation sequencing has incremental value in the diagnostic work-up of patients with suspect pancreatic masses; a multi-center prospective cross sectional studyFriso B Achterberg, Babs G Sibinga Mulder, Quisette P Janssen, et al.
The British Journal of Surgery|February 1, 2025
Preoperative stereotactic radiotherapy to prevent pancreatic fistula in high-risk patients undergoing pancreatoduodenectomy (FIBROPANC): prospective multicentre phase II single-arm trialLeonoor V Wismans, Tessa E Hendriks, J Annelie Suurmeijer, et al.
Gastroenterology|December 26, 2024
Human Enteric Glia Diversity in Health and Disease: New Avenues for the Treatment of Hirschsprung DiseaseJonathan D Windster, Naomi J M Kakiailatu, Laura E Kuil, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 9, 2021
Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancerMarin Strijker, Fleur van der Sijde, Mustafa Suker, et al.
Gut|January 1, 2021
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trialMaria M E Jongsma, Martine A Aardoom, Martinus A Cozijnsen, et al.
Cancers|May 14, 2022
PD-1+ T-Cells Correlate with Nerve Fiber Density as a Prognostic Biomarker in Patients with Resected Perihilar CholangiocarcinomaXiuxiang Tan, Jan Bednarsch, Mika Rosin, et al.
Nature Communications|May 29, 2024
Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLDLars Verschuren, Anne Linde Mak, Arianne van Koppen, et al.
The British Journal of Surgery|July 7, 2023
Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommonMaria J Valkema, Manon C W Spaander, Jurjen J Boonstra, et al.
Nature Communications|November 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancerSongul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg, et al.
Annals of Surgery|May 25, 2026
Pathological Outcomes After Uncertain Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerSanjiv S G Gangaram Panday, Dion In 't Veld, Bianca Mostert, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Plos One|January 25, 2023
Targeted next-generation sequencing has incremental value in the diagnostic work-up of patients with suspect pancreatic masses; a multi-center prospective cross sectional studyFriso B Achterberg, Babs G Sibinga Mulder, Quisette P Janssen, et al.
The British Journal of Surgery|February 1, 2025
Preoperative stereotactic radiotherapy to prevent pancreatic fistula in high-risk patients undergoing pancreatoduodenectomy (FIBROPANC): prospective multicentre phase II single-arm trialLeonoor V Wismans, Tessa E Hendriks, J Annelie Suurmeijer, et al.
Gastroenterology|December 26, 2024
Human Enteric Glia Diversity in Health and Disease: New Avenues for the Treatment of Hirschsprung DiseaseJonathan D Windster, Naomi J M Kakiailatu, Laura E Kuil, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 9, 2021
Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancerMarin Strijker, Fleur van der Sijde, Mustafa Suker, et al.
Gut|January 1, 2021
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trialMaria M E Jongsma, Martine A Aardoom, Martinus A Cozijnsen, et al.
Cancers|May 14, 2022
PD-1+ T-Cells Correlate with Nerve Fiber Density as a Prognostic Biomarker in Patients with Resected Perihilar CholangiocarcinomaXiuxiang Tan, Jan Bednarsch, Mika Rosin, et al.
Nature Communications|May 29, 2024
Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLDLars Verschuren, Anne Linde Mak, Arianne van Koppen, et al.
The British Journal of Surgery|July 7, 2023
Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommonMaria J Valkema, Manon C W Spaander, Jurjen J Boonstra, et al.
Nature Communications|November 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancerSongul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg, et al.
Annals of Surgery|May 25, 2026
Pathological Outcomes After Uncertain Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerSanjiv S G Gangaram Panday, Dion In 't Veld, Bianca Mostert, et al.
Pageof 13